DNL Tag

Diurnal Group PLC – Interim Results

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces its results for the six months ended 31 December 2019 (the "Period")....

Read More

Diurnal Group PLC – Results for the year ended 30 June 2019

[vc_row][vc_column][vc_column_text] Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces its audited results for the year ended 30 June 2019.   Operational highlights   Alkindi® ·      Successful...

Read More

Diurnal Group PLC – Interim Results

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces its results for the six months ended 31 December 2018. ...

Read More

Diurnal Group PLC – Final Results

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces its audited results for the year ended 30 June 2018. ...

Read More